DongKook Pharmaceutical Total Debt vs. Shares Owned By Institutions
| 086450 Stock | KRW 16,640 40.00 0.24% |
For DongKook Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DongKook Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DongKook Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DongKook Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DongKook Pharmaceutical Co over time as well as its relative position and ranking within its peers.
DongKook |
DongKook Pharmaceutical Shares Owned By Institutions vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining DongKook Pharmaceutical's current stock value. Our valuation model uses many indicators to compare DongKook Pharmaceutical value to that of its competitors to determine the firm's financial worth. DongKook Pharmaceutical Co is the top company in total debt category among its peers. It also is number one stock in shares owned by institutions category among its peers . The ratio of Total Debt to Shares Owned By Institutions for DongKook Pharmaceutical Co is about 805,136,767 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DongKook Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DongKook Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.DongKook Total Debt vs. Competition
DongKook Pharmaceutical Co is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 298.64 Trillion. DongKook Pharmaceutical adds roughly 13.69 Billion in total debt claiming only tiny portion of equities under Health Care industry.
DongKook Shares Owned By Institutions vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
DongKook Pharmaceutical |
| = | 13.69 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
DongKook Pharmaceutical |
| = | 17.00 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
DongKook Shares Owned By Institutions Comparison
DongKook Pharmaceutical is currently under evaluation in shares owned by institutions category among its peers.
DongKook Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in DongKook Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DongKook Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of DongKook Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of DongKook Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
DongKook Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on DongKook Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DongKook Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DongKook Pharmaceutical's important profitability drivers and their relationship over time.
Use DongKook Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DongKook Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DongKook Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.DongKook Pharmaceutical Pair Trading
DongKook Pharmaceutical Co Pair Trading Analysis
The ability to find closely correlated positions to DongKook Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DongKook Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DongKook Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DongKook Pharmaceutical Co to buy it.
The correlation of DongKook Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DongKook Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DongKook Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DongKook Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your DongKook Pharmaceutical position
In addition to having DongKook Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities - Regulated Electric Thematic Idea Now
Utilities - Regulated Electric
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities - Regulated Electric theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities - Regulated Electric Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in DongKook Stock
To fully project DongKook Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of DongKook Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include DongKook Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.